FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacology. The invention describes using ipidacrine for treating the locomotor diseases related to the solution of continuity. The above locomotor diseases are fractures, including delayed bone consolidation, delayed knitting, delayed fracture union, pathologic fracture, non-union fracture, and pseudoarthrosis. A pharmaceutical composition for treating the locomotor diseases contains ipidacrine as an active ingredient in an effective amount of 3 to 300 mg per a dose, and a pharmaceutically acceptable excipients. The composition is presented in the form of a tablet or a capsule.
EFFECT: invention extends the application of ipidacrine.
3 cl, 1 dwg, 1 tbl, 3 ex
Authors
Dates
2014-04-10—Published
2012-09-21—Filed